SVB Leerink Starts Zentalis Pharmaceuticals (ZNTL) at Outperform
Tweet
Share
E-mailGet Alerts ZNTL Hot Sheet
Price: $3.56 -14.22%
Rating Summary:
8 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
SVB Leerink analyst Andrew Berens initiates coverage on Zentalis Pharmaceuticals (NASDAQ: ZNTL) with a Outperform rating and a price target of $45.00.
For an analyst ratings summary and ratings history on Zentalis Pharmaceuticals click here. For more ratings news on Zentalis Pharmaceuticals click here.
Shares of Zentalis Pharmaceuticals closed at $31.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zentalis Pharmaceuticals prices $80.5M public stock offering
- Leerink Starts Ligand Pharma (LGND) at Outperform
- Lake Street Starts RF Industries Ltd. (RFIL) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Andrew BerensSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
